Algemeen Ziekenhuis Delta

SOPHiA GENETICS Partners with Belgium's Jessa Ziekenhuis to Advance Precision Oncology Through AI-Driven Genomic Platform

- SOPHiA GENETICS has announced a strategic collaboration with Jessa Ziekenhuis, one of Belgium's largest healthcare institutions serving over 530,000 patients, to implement the SOPHiA DDM™ platform for unified next-generation sequencing workflows. - The partnership will deploy six specialized applications for solid tumors, hematologic malignancies, and liquid biopsy analysis, with expected efficiency gains including 30-50% reduction in hands-on time and up to 25% cost savings. - The collaboration establishes the Bridge Consortium with AZ Delta hospital to share NovaSeq sequencing capacity, demonstrating a novel model for resource optimization in precision oncology across European healthcare networks.